跳至主要内容
临床试验/NCT05809557
NCT05809557已完成不适用

Effect of an EMR Chemotoxicity Risk Calculator Availability To Decrease Chemotherapy Toxicity in Adults With Cancer

Masonic Cancer Center, University of Minnesota2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年1月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
2
主要终点
Unplanned hospitalization rate

研究概览

简要总结

This study will formally test the quality improvement intervention of an EMR based tool that informs medical oncologists visiting a patient for the first time of potential risk of chemotherapy toxicity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • New outpatient visits with a medical oncologist following a new diagnosis of cancer and no prior history of chemotherapy treatment.
  • aged > 65 will be included.

排除标准

  • Patients who opt out of clinical research will be excluded from analysis, but not the intervention (which will be applied to all patients). Specifically, as sometimes opt-in/opt out status is coded ambiguously in the data we will only analyze results of patients with clear opt in and no history of opt out.
  • Patients with no EHR data after initial oncologist appointment.

结局指标

主要结局

Unplanned hospitalization rate

时间窗: Within 3 months of the Index Visit with the oncologist

Measured at the patient level as a binary outcome (yes/no) based on date of initial visit with the oncologist.

次要结局

  • Chemotherapy toxicity tool use rate(Within 3 months of the Index Visit with the oncologist)
  • Palliative Care Referral(Within 6 months of the Index Visit with the oncologist)
  • Healthcare contact days(Within 3 and 6 months of the Index Visit with the oncologist)
  • Chemotherapy use rate(Within 3 months of the Index Visit with the oncologist)
  • Chemotherapy modification rate(Within 3 months of the Index Visit with the oncologist)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验